ARTICLE | Cancerworld: AI-generated radiotherapy planning could boost access to high-quality treatment across the globe

This article from Cancerworld gives an overview of the ARCHERY study and its aims to widen access to effective radiotherapy treatment.

"Faster, cheaper, higher throughput of patients, with no loss of quality. We’re getting used to hearing these claims for the potential of AI apps in healthcare. An international study is now set to put them to the test, trialling what AI-generated radiation therapy planning can deliver for patients treated in resource-poor countries for head and neck, cervical and prostate cancer."

Read the full article on the Cancerworld website.

Archery is funded by Rising Tide and NIH